UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Wick Capital Partners LLC

Wick Capital Partners LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 273.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,798 shares of the healthcare conglomerate's stock after purchasing an additional 1,317 shares during the period. Wick Capital Partners LLC's holdings in UnitedHealth Group were worth $910,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $28,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $30,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group during the 4th quarter valued at $30,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $11.37 during mid-day trading on Thursday, hitting $400.07. The stock had a trading volume of 9,289,533 shares, compared to its average volume of 4,571,255. UnitedHealth Group Incorporated has a 52 week low of $399.53 and a 52 week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $364.15 billion, a price-to-earnings ratio of 25.81, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a 50 day simple moving average of $497.29 and a 200-day simple moving average of $529.82.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the company earned $6.91 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.10%. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on UNH shares. KeyCorp lowered their target price on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Erste Group Bank raised shares of UnitedHealth Group to a "strong-buy" rating in a report on Wednesday, April 16th. Finally, Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.